Natural history of chronic HBV infection: A cohort study with up to 12 years follow-up in North Greece (part of the interreg I-II/EC-project)

Journal of Medical Virology

Volumn 77, Issue 2, 2005, Pages 173-179

  Zacharakis, G H ^a,b   Koskinas, J ^b   Kotsiou, S ^c   Papoutselis, M ^a   Tzara, F ^a   Vafeiadis, N ^a   Archimandritis, A J ^b   Papoutselis, K ^a  

^a Social Security Institute   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Follow up; HBsAG inactive carriers; HBV infection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DETERIORATION; DISEASE MARKER; ENDEMIC DISEASE; EVALUATION; FEMALE; FOLLOW UP; GREECE; HEPATITIS B VIRUS; HETEROZYGOTE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SEROCONVERSION; TREATMENT OUTCOME; VIRUS REACTIVATION;

ADULT; AGED; ALANINE TRANSAMINASE; CARRIER STATE; COHORT STUDIES; DNA, VIRAL; FEMALE; GREECE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; VIREMIA;

HEPATITIS B VIRUS;

EID: 24644509189     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20434     Document Type: Article

References (50)

1. Alward WLM, McMathon BJ, Hall DB, Heyward WL, Bender TR, Francis DP, Maynard J-E. 1985. The long term serologic course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis 151:604-609.
2. Bellentani S, Dal Molin G, Miglioli L, Saveria Croce L, Massuti F, Castiglione A, Campello C, Tiribelli C. 2002. Natural history of HBV infection: A 9 years follow-up of the Dionysus cohort. J Hepatol 36:228.
3. Bortolloti F, Cadrobbi P, Crivellaro C, Guido M, Rugge M. 1990. Long term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Castroenterology 99:805-810.
4. Bortolotti F, Jara P, Crivellaro C, Hierro L, Cadrobbi P, Frauca E, Camarena C, De La Vega A, Diaz C, De Moliner L, Noventa F. 1998. Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 29:184-190.
5. Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, Gorin JM, Bonino F. 2002. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: A long-term cohort study. J Hepatol 36:263-270.
6. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, Cova L, Chevallier P, Mandrand B, Trepo C. 2001. High incidence of hepatitis B infections among chronic hepatitis cases of unknown etiology. J Hepatol 34:471-479.
7. Chisari FV, Ferrari C. 1995. Hepatitis B virus immunopathogenesis. Ann Rev Immunol 13:29-60.
8. De Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G. 1993. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118:191-194.
9. De Jongh FE, Janssen HLA, De Mann RA, Hopw CJ, Schalm SW, Von Blankestein MV. 1992. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology 103:1630-1635.
10. Di Marco V, Lo Iacono O, Gamma C, Vaccaro A, Giunta M, Martorana G, Fuschi P, Almasio PL, Craxi A. 1999. The long-term course of chronic Hepatitis B. Hepatology 30:257-264.
11. Dragosic B, Ferenci P, Hitachan E, Denk H. 1987. Long term follow-up study of asymptomatic HBsAg-positive voluntary blood donors in Austria. A clinical and histological evaluation of 242 cases. Hepatology 7:302-306.
12. Evans AA, Fine M, London WT. 1997. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: Implication for interferon therapy. J Infect Dis 176:845-850.
13. Farci P. 2003. Delta Hepatitis: An update. J Hepatol 39:8212-8219.
14. Fattovich G, Ruge M, Brollo L, Pontisso P, Noventa F, Guid M. 1986. Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 6:167-172.
15. Fattovich G, Brollo L, Alberti A, Pontisso P, Giustin G, Realdi G. 1988. Long-term follow-up of anti-HBe positive chronic active hepatitis B. Hepatology 8:1651-1654.
16. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, Ruol A. 1991. Natural history and prognostic factors for chronic hepatitis type B. Gut 32:294-298.
17. Fattovich G, Giustina G, Sanchez-Tapias J, Quero C, Mas A, Olivotto PG, Solinas A, Almasio P, Hadziyannis S, Degos F, de Moura MC, Krogsgaard K, Pantalena M, Realdi G, Corrocher R, Schalm SW. 1998. Delayed clearance of serum HBsAg in compensated cirrhosis B: Relation to interferon a therapy and disease prognosis. Am J Gastroenterol 93:896-900.
18. Hadziyannis SJ, Vassilopoulos D. 2001a. Hepatitis B e antigen-negative chronic hepatitis B. Hepatology 34:617-624.
19. Hadziyannis SJ, Vassilopoulos D. 2001b. Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res 52:91-98.
20. Hadziyannis S, Bramou T, Alexopoulou A, Makris A. 1991. Immunopathogenesis and natural course of anti-HBe positive chronic hepatitis with replicating B virus. In: Hollinger FB, Lemon SM, Margolis N, editors. Viral hepatitis and liver diseases. Baltimore, Maryland: Williams and Wilkins. pp 673-676.
21. Hoofnagle JH. 2000. The clinical spectrum and course of chronic hepatitis B. Management of chronic hepatitis B 2000. NIH, Bethesda.
22. Hoofnagle JH, Shafritz DA, Popper H. 1987. Chronic type B hepatitis and the "healthy" HBsAg carrier state. Hepatology 7:758-763.
23. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF. 2002. Long-term outcome following spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35:1522-1527.
24. Kawatani T, Suou T, Tajima F, Ishiga K, Omura H, Endo A, Ohmura H, Ikuta Y, Idobe Y, Kawasaki H. 2001. Incidence of hepatitis B virus infection and severe liver dysfunction in patients receiving chemotherapy for histologic malignancies. Eur J Haematol 67: 45-50.
25. Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733-1745.
26. Liaw YF. 1997. Current therapeutic trends in therapy for chronic viral hepatitis. J Gastroenterol Hepatol 12:8346-8353.
27. Liaw YF, Chu CM, Su IJ, Huang MJ, Lin DY, Chang Chien CS. 1983. Clinical and histological events preceeding hepatitis B e antigen seroconversion in chronic type B hepatitis. Gastroenterology 84:216-219.
28. Liaw YF, Chu CM, Huang MJ, Sheen IS, Yang CY, Lin DY. 1984. Determinants for hepatitis B e antigen clearance in chronic type B hepatitis. Liver 4:301-306.
29. Liaw YF, Tai DI, Chu CM, Chen TJ. 1988. The development of cirrhosis in patients with chronic type B hepatitis: A prospective study. Hepatology 8:493-496.
30. Lok ASF, McMahon BJ. 2001. Chronic Hepatitis B. Hepatology 34:1225-1241.
31. Lok ASF, McMahon BJ. 2004. Chronic Hepatitis B: Update of recommendations. AASLD Practice Guideline. Hepatology 39:857-861.
32. Lok ASF, Lai CL, Wu PC, Leung EKY, Lam TS. 1987. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 92:1839-1843.
33. Lok AS, Heathcote EJ, Hoofnage JH. 2001. Management of hepatitis B: 2000-summary of a workshop. Gastroenterology 120:1828-1853.
34. Maddrey WC. 2000. Hepatitis B: An important public health issue. J Med Virol 61:362-366.
35. Manesis EK, Papatheodoridis GV, Sevastianos V, Cholongitas E, Papaioannou C, Hadziyannis SJ. 2003. Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infection. Am J Gastroenterol 98:2261-2267.
36. Manno M, Cammà M, Schepis F, Bassi F, Gelmini R, Giannini F, Miselli F, Grottola A, Ferretti I, Vecchi C, De Palma M, Villa E. 2004. Natural history of chronic HBV carriers in Northern Italy: Morbidity and mortality after 30 years. Gastroenterology 127: 756-763.
37. Martinot-Peignoux M, Boyer N, Colombat M, Akremi R, Pham BN, Ollivier S, Castelnau C, Valla D, Degott C, Marcellin P. 2002. Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers. J Hepatol 36:543-546.
38. Mast EE, Alter MJ, Margiolis HS. 1999. Strategies to prevent and control hepatitis B and C virus infections: A global prospective. Vaccine 17:1730-1733.
39. McMahon BJ, Holck P, Bulkow L, Snowball M. 2001. Serologic and clinical outcome of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Internal Med 135:759-768.
40. Papatheodoridis GV, Manesis E, Hadziyannis S. 2001. The long-term outcome of interferon-a treated and untreated patients with HBeAg-negative chronic hepatitis B. J Hepatol 34:306-311.
41. Papoutselis KM, Kotsiou SS, Zacharakis G, Tzara F, Vafeiadis N. 2001. Epidemiology of hepatitis B and C viral infections in minorities of thrace: Immigrants from the former USSR and residents with low socioeconomic status in relation to the general population of thrace. J Hepatol 34:175.
42. Perillo RP. 2001. Acute flares in chronic hepatitis B: The natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 120:1009-1022.
43. Sakuma K, Takahara T, Okuda K, Tsuda F, Mayumi M. 1982. Prognosis of hepatitis B surface antigen carriers in relation with routine liver function tests: A prospective study. Gastroenterology 83:114-117.
44. Sanchez-Tapias JM, Costa J, Mas A, Bruguera M, Rodes J. 2002. Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in Western patients. Gastroenterology 123:1848-1856.
45. Scheur PJ. 1991. Classification of chronic hepatitis: A need for reassessment. J Hepatol 13:372-374.
46. Velasco M, Gonzales-Ceron M, De la Fuente C, Ruiz A, Donso S, Katz R. 1978. Clinical and pathological study of asymptomatic HBsAg carriers in Chile. Gut 19:569-571.
47. Villeneuve JP, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M, Cote J, Richer G. 1994. A long term follow-up study of asymptomatic HBsAg positive carriers in Montreal. Gastroenterology 106:1000-1005.
48. Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB. 1984. Survival in chronic hepatitis B. Ann Intern Med 101:613-616.
49. Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ, Taiwan Community-Based Cancer Screening Project Group. 2002. Hepatitis B e-antigen and the risk of hepatocellular carcinoma. N Eng J Med 347:168-174.
50. Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL. 2001. Long term follow-up of interferon treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Hepatology 34:139-145.